Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013

Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe bacterial meningitis epidemiology, focusing on pneumococcal men...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2016-11, Vol.11 (11), p.e0166384-e0166384
Main Authors: Kambiré, Dinanibè, Soeters, Heidi M, Ouédraogo-Traoré, Rasmata, Medah, Isaïe, Sangare, Lassana, Yaméogo, Issaka, Sawadogo, Guetawendé, Ouédraogo, Abdoul-Salam, Hema-Ouangraoua, Soumeya, McGee, Lesley, Srinivasan, Velusamy, Aké, Flavien, Congo-Ouédraogo, Malika, Sanou, Soufian, Ba, Absatou Ky, Novak, Ryan T, Van Beneden, Chris
Format: Article
Language:English
Subjects:
Adolescent
Adult
Adults
Agglutination
Bacteria
Bacterial meningitis
Biology and Life Sciences
Burkina Faso - epidemiology
Cerebrospinal fluid
Child
Child, Preschool
Children
De Gaulle, Charles (1890-1970)
Demographics
Development and progression
Disease control
Epidemics
Epidemiology
Female
Haemophilus influenzae
Health aspects
Humans
Immunization
Incidence
Infant
Latex
Latex agglutination
Male
Medicine and Health Sciences
Meningitis
Meningitis, Bacterial - diagnosis
Meningitis, Bacterial - epidemiology
Meningitis, Bacterial - prevention & control
Meningitis, Pneumococcal - diagnosis
Meningitis, Pneumococcal - epidemiology
Meningitis, Pneumococcal - prevention & control
Morbidity
Neisseria meningitidis
People and places
Pneumococcal Vaccines - therapeutic use
Pneumonia
Polymerase chain reaction
Real time
Research and Analysis Methods
Serotypes
Serotyping
Streptococcus infections
Streptococcus pneumoniae
Streptococcus pneumoniae - classification
Vaccines
Vaccines, Conjugate - therapeutic use
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe bacterial meningitis epidemiology, focusing on pneumococcal meningitis, before 13-valent pneumococcal conjugate vaccine (PCV13) introduction in the pediatric routine immunization program in October 2013. Nationwide population-based meningitis surveillance collects case-level demographic and clinical information and cerebrospinal fluid (CSF) laboratory results. Sp infections are confirmed by culture, real-time polymerase chain reaction (rt-PCR), or latex agglutination, and CSF serotyped using real-time and conventional PCR. We calculated incidence rates in cases per 100,000 persons, adjusting for age and proportion of cases with CSF tested at national reference laboratories, and case fatality ratios (CFR). During 2011-2013, 1,528 pneumococcal meningitis cases were reported. Average annual adjusted incidence rates were 26.9 (
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0166384